Premium
Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse
Author(s) -
Schuler Michael,
Dierich Andrée,
Chambon Pierre,
Metzger Daniel
Publication year - 2004
Publication title -
genesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.093
H-Index - 110
eISSN - 1526-968X
pISSN - 1526-954X
DOI - 10.1002/gene.20039
Subject(s) - cre recombinase , somatic cell , biology , microbiology and biotechnology , gene , allele , coding region , transgene , tamoxifen , wild type , genetically modified mouse , genetics , mutant , cancer , breast cancer
To generate temporally controlled targeted somatic mutations selectively and efficiently in hepatocytes, we established SA +/CreERT2 mice in which the tamoxifen‐dependent Cre‐ER T2 recombinase coding sequence preceded by an internal ribosomal entry site was inserted in the 3′ untranslated region of the serum albumin (SA) gene. Whereas the wildtype SA allele was strongly expressed in the liver and at lower levels in some extrahepatic tissues, SA‐Cre‐ER T2 fusion transcripts were only detected in the liver. The Cre‐ER T2 protein was expressed in most if not all hepatocytes, and tamoxifen (Tam) treatments of adult mice at various ages efficiently induced Cre‐mediated recombination of LoxP flanked (floxed) alleles in these cells, but none in other cell types or tissues. Thus, SA +/CreERT2 mice should be of great value to analyze gene function in the liver and to establish animal models of human diseases. genesis 39:167–172, 2004. © 2004 Wiley‐Liss, Inc.